American Portfolios Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$51K Buy
2,178
+288
+15% +$8.7K ﹤0.01% 1687
2022
Q2
$63.8K Sell
1,890
-197
-9% -$6.9K ﹤0.01% 1634
2022
Q1
$72.9K Sell
2,087
-318
-13% -$10.9K ﹤0.01% 1701
2021
Q4
$73.2K Sell
2,405
-83
-3% -$2.7K ﹤0.01% 1685
2021
Q3
$81.6K Buy
2,488
+154
+7% +$4.93K ﹤0.01% 1542
2021
Q2
$70.6K Buy
+2,334
New +$76.8K ﹤0.01% 1561

Other funds holding OGN

American Portfolios Advisors's OGN Position: Q3 2022 in Review

American Portfolios Advisors increased its Organon & Co (OGN) stake by 15% in Q3 2022, buying an estimated $8.7K and bringing the position to 2,178 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

American Portfolios Advisors first reported a position in OGN in Q2 2021 and has held it in 6 quarters since. The position peaked at $81.6K in Q3 2021. 792 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • American Portfolios Advisors held 2,178 shares of Organon & Co worth $51K as of Q3 2022.
  • American Portfolios Advisors bought 288 Organon & Co shares in Q3 2022, an estimated $8.7K.
  • Organon & Co made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1687 holding.
  • American Portfolios Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 6 quarters since.
  • American Portfolios Advisors's Organon & Co position peaked at $81.6K in Q3 2021.
  • 792 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.